In this Analysis, we searched for relevant literature on the effects of GLP-1RAs across a range of illnesses, gathering and describing the available pre-clinical and mechanistic (278 studies) and clinical (96 studies) evidence for cognitive disorders, substance-use disorders, psychotic disorders, mood and anxiety disorders, eating disorders, and others
The content is the sole responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Duke Clinical and Translational Science Institute.
GHK-Cu supplied by Research Peptides is designated strictly as a laboratory research compound
Teicher BA, Polley E, Kunkel M, Evans D, Silvers T, Delosh R, et al
The clinical evidence and real-world results strongly suggest that it is one of the most powerful tools currently available for blood sugar regulation and weight management
Both approaches are valid